ストックスクリーナーアプリを入手
1.11
0.91%
0.01
前日終値:
$1.10
開ける：
$1.1
24時間の取引高:
1.74M
Relative Volume:
0.88
時価総額：
$203.48M
収益：
$137.74M
当期純損益:
$-27.97M
株価収益率:
-6.9375
EPS:
-0.16
ネットキャッシュフロー:
$-9.61M
1週間 パフォーマンス:
-5.93%
1か月 パフォーマンス:
-13.28%
6か月 パフォーマンス:
-47.39%
1年 パフォーマンス:
-36.57%
1日の値動き範囲:
$1.08
$1.115
1週間の範囲:
$1.05
$1.19
52週間の値動き範囲:
$1.04
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
名前
Heron Therapeutics Inc
セクター
電話
(858) 251-4400
住所
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.11 | 201.70M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-09 | 開始されました | H.C. Wainwright | Buy |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-23 | 開始されました | CapitalOne | Overweight |
| 2024-03-13 | 繰り返されました | Needham | Buy |
| 2020-05-27 | 開始されました | Guggenheim | Buy |
| 2020-02-20 | 繰り返されました | Needham | Buy |
| 2019-01-16 | 繰り返されました | Needham | Buy |
| 2018-04-05 | 開始されました | Evercore ISI | Outperform |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2018-03-01 | 繰り返されました | Needham | Buy |
| 2018-01-03 | 開始されました | Leerink Partners | Outperform |
| 2017-09-27 | 開始されました | Northland Capital | Outperform |
| 2017-02-27 | 開始されました | Needham | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-09-06 | 再開されました | Lake Street | Buy |
| 2016-05-03 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-12-10 | 開始されました | Lake Street | Buy |
| 2015-09-23 | 繰り返されました | Leerink Partners | Outperform |
| 2015-09-02 | 開始されました | BofA/Merrill | Buy |
| 2015-08-03 | 繰り返されました | Brean Capital | Buy |
| 2015-06-30 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2015-06-19 | 繰り返されました | Leerink Partners | Outperform |
| 2014-08-07 | 開始されました | Noble Financial | Buy |
すべてを表示
Heron Therapeutics Inc (HRTX) 最新ニュース
Ranking Heron Therapeutics Inc. among high performing stocks via toolsTrade Volume Summary & Stock Market Timing Techniques - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could rally stronglyQuarterly Market Review & Consistent Profit Trading Strategies - newser.com
Heron Therapeutics Inc. stock daily chart insightsRisk Management & Daily Risk Controlled Trade Plans - newser.com
Heron Therapeutics Inc. stock chart pattern explained2025 Top Gainers & Technical Pattern Alert System - newser.com
Will Heron Therapeutics Inc. stock benefit from automation2025 Dividend Review & Community Driven Trade Alerts - newser.com
Sentiment analysis tools applied to Heron Therapeutics Inc.Quarterly Trade Summary & Verified Entry Point Signals - newser.com
Can Heron Therapeutics Inc. stock weather global recessionPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com
What analysts say about Heron Therapeutics Inc AXD2 stockSector-Based Investing & Free Smart Stock Picking Tools - earlytimes.in
What is Northland Capmk's Estimate for HRTX FY2026 Earnings? - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported, And Analysts Assigned A US$4.50 Price Target - simplywall.st
Is Heron Therapeutics Inc. (AXD2) stock inflation resilientWeekly Trend Report & Free Growth Oriented Trading Recommendations - newser.com
[Form 3] HERON THERAPEUTICS, INC. /DE/ Initial Statement of Beneficial Ownership - Stock Titan
What is HC Wainwright's Forecast for HRTX FY2025 Earnings? - MarketBeat
What analyst consensus says on Heron Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Momentum Watchlists - newser.com
Tools to monitor Heron Therapeutics Inc. recovery probability2025 Top Decliners & Daily Growth Stock Investment Tips - newser.com
Heron Therapeutics: Stagnant Cash Cow, Blockbuster That Wasn'tSteer Clear - Seeking Alpha
Will Heron Therapeutics Inc. stock attract more institutional investorsJuly 2025 Price Swings & High Return Trade Guides - newser.com
What is HC Wainwright's Forecast for HRTX FY2027 Earnings? - MarketBeat
Heron Therapeutics Inc. stock prediction for this weekTrend Reversal & Consistent Growth Stock Picks - newser.com
Heron Therapeutics outlines $153M–$163M net revenue target as acute care momentum accelerates - MSN
Should you wait for a breakout in Heron Therapeutics Inc.Earnings Growth Report & High Accuracy Swing Trade Signals - newser.com
Can trapped investors hope for a rebound in Heron Therapeutics Inc.Weekly Gains Report & Real-Time Market Sentiment Alerts - newser.com
Developing predictive dashboards with Heron Therapeutics Inc. dataJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
What MACD and RSI say about Heron Therapeutics Inc.Market Performance Recap & Verified Technical Trade Signals - newser.com
Why Heron Therapeutics Inc. (AXD2) stock attracts wealthy investorsQuarterly Portfolio Review & High Accuracy Swing Trade Signals - newser.com
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Heron Therapeutics Q3 2025 slides: strong product growth despite earnings miss - Investing.com Australia
Heron Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - MSN
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2025 Earnings Call Transcript - Insider Monkey
Heron Therapeutics’ Earnings Call: Growth Amid Challenges - MSN
Heron Therapeutics: Q3 Earnings Snapshot - CT Insider
Detecting price anomalies in Heron Therapeutics Inc. with AIQuarterly Investment Review & AI Forecasted Stock Moves - newser.com
Can Heron Therapeutics Inc. recover in the next quarterMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
Heron Therapeutics Reports Strong Q3 2025 Revenue Growth - TipRanks
What analysts say about Heron Therapeutics Inc stockGeopolitical Risk Analysis & Low Entry Investment Growth - earlytimes.in
Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline - Investing.com Canada
Heron Therapeutics (HRTX): Forecasts Signal 60.89% Annual Earnings Growth, Path to Profitability in Focus - Yahoo Finance
Heron Therapeutics Inc (HRTX) 財務データ
収益
当期純利益
現金流量
EPS
Heron Therapeutics Inc (HRTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
0.05%
1.40%
大文字化:
|
ボリューム (24 時間):